Comparison of Left Ventricular Hypertrophy by Electrocardiography and Echocardiography in Children Using Analytics Tool
Left ventricular hypertrophy (LVH) is a common finding on pediatric electrocardiography (ECG) leading to many referrals for echocardiography (echo). This study utilizes a novel analytics tool that combines ECG and echo databases to evaluate ECG as a screening tool for LVH. SQL Server 2012 data warehouse incorporated ECG and echo databases for all patients from a single institution from 2006 to 2016. Customized queries identified patients 0–18 years old with LVH on ECG and an echo performed within 24 h. Using data visualization (Tableau) and analytic (Stata 14) software, ECG and echo findings were compared. Of 437,699 encounters, 4637 met inclusion criteria. ECG had high sensitivity (≥ 90%) but poor specificity (43%), and low positive predictive value (< 20%) for echo abnormalities. ECG performed only 11–22% better than chance (AROC = 0.50). 83% of subjects with LVH on ECG had normal left ventricle (LV) structure and size on echo. African-Americans with LVH were least likely to have an abnormal echo. There was a low correlation between V6R on ECG and echo-derived Z score of left ventricle diastolic diameter (r = 0.14) and LV mass index (r = 0.24). The data analytics client was able to mine a database of ECG and echo reports, comparing LVH by ECG and LV measurements and qualitative findings by echo, identifying an abnormal LV by echo in only 17% of cases with LVH on ECG. This novel tool is useful for rapid data mining for both clinical and research endeavors.
KeywordsLeft ventricular hypertrophy Electrocardiography Echocardiography
Compliance with Ethical Standards
Conflict of interest
A collaborator contractual agreement has been completed and signed between Philips Healthcare, a division of Philips Electronics North America Corporation, and Children’s National Health System, division of cardiology. There exist no financial interests for the investigator or provider institutions in the outcome of the research.
Research Involving Human and Animal Participants
This article does not contain any studies with human participants or animals performed by any of the authors.
- 4.Corrado D, Pelliccia A, Bjornstad HH, Vanhees L, Biffi A, Borjesson M et al (2005) Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol: consensus statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 26:516–524CrossRefGoogle Scholar
- 7.Maron BJ, Thompson PD, Ackerman MJ, Balady G, Berger S, Cohen D et al (2007) Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 115:1643–1655CrossRefGoogle Scholar
- 12.Rivenes SM, Colan SD, Easley KA, Kaplan S, Jenkins KJ, Khan MN et al (2003) Usefulness of the pediatric electrocardiogram in detecting left ventricular hypertrophy: results from the prospective pediatric pulmonary and cardiovascular complications of vertically transmitted HIV infection (P2C2 HIV) multicenter study. Am Heart J 145:716–723CrossRefGoogle Scholar
- 19.Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al (2005) Recommendations for chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 18:1454–1457CrossRefGoogle Scholar
- 20.StataCorp. (2015) Stata statistical software: release 14. College Station, TX: StataCorp LPGoogle Scholar
- 27.Hancock EW, Deal BJ, Mirvis DM, Okin P, Kligfield P, Gettes LS (2009) AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram part V: electrocardiogram changes associated with cardiac chamber hypertrophy a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Circulation 119:e251–e261CrossRefGoogle Scholar